JPS4935410B1 - - Google Patents

Info

Publication number
JPS4935410B1
JPS4935410B1 JP11947870A JP11947870A JPS4935410B1 JP S4935410 B1 JPS4935410 B1 JP S4935410B1 JP 11947870 A JP11947870 A JP 11947870A JP 11947870 A JP11947870 A JP 11947870A JP S4935410 B1 JPS4935410 B1 JP S4935410B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11947870A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4935410B1 publication Critical patent/JPS4935410B1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP11947870A 1970-01-15 1970-12-28 Pending JPS4935410B1 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702001604 DE2001604C2 (de) 1970-01-15 1970-01-15 Verwendung von Polyäthylenglykol zur Herstellung von Oxytetracyclinlösungen zur parenteralen, peroralen und lokalen Anwendung

Publications (1)

Publication Number Publication Date
JPS4935410B1 true JPS4935410B1 (hu) 1974-09-21

Family

ID=5759662

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11947870A Pending JPS4935410B1 (hu) 1970-01-15 1970-12-28

Country Status (4)

Country Link
JP (1) JPS4935410B1 (hu)
DE (1) DE2001604C2 (hu)
FR (1) FR2081434B1 (hu)
GB (1) GB1286351A (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007326875A (ja) * 1994-07-09 2007-12-20 Norbrook Lab Ltd 長時間作用オキシテトラサイクリン組成物

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1163197A (en) * 1980-04-10 1984-03-06 Herman Horn Injectable oxytetracycline compositions
US6110905A (en) * 1994-07-09 2000-08-29 Norbrook Laboratories Limited Long-acting oxytetracycline composition
US8545831B2 (en) 2005-05-31 2013-10-01 Warsaw Orthopedic, Inc. Compositions and methods for treating a damaged cardiovascular element
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US8945623B2 (en) * 2006-05-03 2015-02-03 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US20080039433A1 (en) * 2006-06-15 2008-02-14 Smith Alexander D Stabilized Tetracycline Compositions
US8057458B2 (en) 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US9675696B2 (en) 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
US9078808B2 (en) 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation
US8852566B2 (en) 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US9244060B2 (en) 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
CN102438657A (zh) 2009-03-26 2012-05-02 沃萨乌整形外科公司 鉴别定向药物递送组合物的潜在组分的方法
US8858924B2 (en) 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017323A (en) * 1957-07-02 1962-01-16 Pfizer & Co C Therapeutic compositions comprising polyhydric alcohol solutions of tetracycline-type antibiotics

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007326875A (ja) * 1994-07-09 2007-12-20 Norbrook Lab Ltd 長時間作用オキシテトラサイクリン組成物

Also Published As

Publication number Publication date
FR2081434A1 (hu) 1971-12-03
DE2001604C2 (de) 1983-04-14
FR2081434B1 (hu) 1974-08-30
DE2001604A1 (de) 1971-08-19
GB1286351A (en) 1972-08-23

Similar Documents

Publication Publication Date Title
AR204384A1 (hu)
FR2081434A1 (hu)
ATA96471A (hu)
AU2044470A (hu)
AU1833270A (hu)
AU2017870A (hu)
AU2085370A (hu)
AU2130570A (hu)
AU442343B2 (hu)
AR195465A1 (hu)
AU2112570A (hu)
ATA672271A (hu)
AU1832970A (hu)
AU2144270A (hu)
AU1841070A (hu)
AU1872870A (hu)
AU1879170A (hu)
AU1881070A (hu)
AU1918570A (hu)
AU1247570A (hu)
AU2061170A (hu)
AU1004470A (hu)
AU1943370A (hu)
AU1974970A (hu)
AU2115870A (hu)